Clinical Trial Update: Minimally Invasive Surfactant Therapy Followed by CPAP (MISTCPAP) in Preterm Infants With RDS [Phase 2]

View source ↗

Summary

This document describes a Phase 2 clinical trial evaluating minimally invasive surfactant therapy followed by CPAP (MISTCPAP) in preterm infants with respirator…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome

Drugs mentioned

• Minimally Invasive Surfactant Therapy followed by CPAP (MISTCPAP)

Snippet

Sponsor: China Medical University Hospital | Conditions: Respiratory Distress Syndrome | Phase 2 | Status: UNKNOWN